CLONING AND CHARACTERIZATION OF HUMAN CYP25
人 CYP25 的克隆和表征
基本信息
- 批准号:6838215
- 负责人:
- 金额:$ 21.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-02-01 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Vitamin D must undergo
hydroxylation to 25-hydroxyvitamin D [25(OH)D] by the enzyme vitamin
D-25-hydroxylase (CYP25) to become biologically active. Porcine CYP25 cDNA was
cloned and characterized. The gene encodes a cytochrome P450 microsomal enzyme
expressed in liver and kidney that catalyzes the conversion of vitamins D2 and
D3 to 25(OH)D3, respectively. Patients with isolated 25(OH)D deficiency and
rickets who respond to pharmacologic doses of vitamin D and physiologic doses
of 25(OH)D3, 1alpha(OH)D3, or related drugs are presumed to have CYP25
deficiency. The specific aims of this proposal are to use portions of porcine
CYP25 cDNA to isolate and characterize human CYP25 cDNA, to clone and
characterize the human CYP25 gene, to determine chromosome locus of CYP25 DNA
and tissue expression of CYP25 mRNA, to use gene mapping, linkage analysis and
positional cloning, to characterize family pedigrees and determine molecular
mechanisms of patients with isolated 25(OH)D deficiency and rickets, to
characterize CYP25 gene polymorphisms in affected populations, and to correlate
genotype with phenotype. The fact that porcine CYP25 cDNA has 83 percent
homology with human CYP2D6 cDNA, a cytochrome P450 microsomal enzyme that plays
a role in drug metabolism, has interfered with cloning of human CYP25 cDNA. Pig
liver extracts are reported to have no CYP2DK activity. Using a radiation
hybrid cell panel (ImpRH), we found that the porcine CYP25 gene maps to pig
chromosome 5p14-15 close to the ACO2 gene, a region syntenic ot human
chromosome 22q12-13 where human CYP2D6 was mapped. We used haplotype analysis
of family pedigrees of patients with isolated CYP25 deficiency and rickets and
found that the disease does not map to either the CYP2D6 gene locus or
chromosome 22. The results of the proposed studies should provide important new
information about the molecular structure and chromosomal locus of the CYP25
gene and the molecular causes of isolated 25(OH)D and rickets.
描述(改编自申请人摘要):维生素D必须经历
通过维生素D酶羟基化为25-羟基维生素D [25(OH)D]
D-25-羟化酶(CYP 25)变得具有生物活性。猪CYP 25 cDNA是
克隆并鉴定。该基因编码细胞色素P450微粒体酶
在肝脏和肾脏中表达,催化维生素D2的转化,
D3至25(OH)D3。孤立性25(OH)D缺乏症患者,
对药理剂量和生理剂量的维生素D有反应的佝偻病
25(OH)D3、1 α(OH)D3或相关药物中的一种被推定为具有CYP 25
缺陷该提案的具体目标是使用猪的部分
CYP 25 cDNA,分离和表征人CYP 25 cDNA,
表征人CYP 25基因,以确定CYP 25 DNA的染色体位点
和组织表达,利用基因定位,连锁分析,
定位克隆,以表征家族谱系和确定分子
孤立性25(OH)D缺乏症和佝偻病患者的机制,
表征受影响人群中的CYP 25基因多态性,
基因型与表型。事实上,猪CYP 25 cDNA具有83%的
与人CYP 2D 6 cDNA同源,这是一种细胞色素P450微粒体酶,
在药物代谢中的作用,干扰了人CYP 25 cDNA的克隆。猪
据报道肝提取物没有CYP 2DK活性。使用辐射
杂交细胞面板(ImpRH),我们发现猪CYP 25基因定位到猪
染色体5 p14 -15与人类同线的ACO 2基因相邻
染色体22 q12 -13,其中人类CYP 2D 6被定位。我们用单倍型分析
孤立性CYP 25缺乏症和佝偻病患者的家族谱系,
发现这种疾病既不映射到CYP 2D 6基因位点,
22号染色体。拟议研究的结果应提供重要的新的
关于CYP 25的分子结构和染色体位点的信息
基因和孤立的25(OH)D和佝偻病的分子原因。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterization of recombinant CYP2C11: a vitamin D 25-hydroxylase and 24-hydroxylase.
- DOI:10.1152/ajpendo.00201.2004
- 发表时间:2005-04
- 期刊:
- 影响因子:0
- 作者:Mehrdad Rahmaniyan;K. Patrick;N. Bell
- 通讯作者:Mehrdad Rahmaniyan;K. Patrick;N. Bell
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NORMAN H BELL其他文献
NORMAN H BELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NORMAN H BELL', 18)}}的其他基金
Cloning and Characterization of Human CYP 25
人类 CYP 25 的克隆和表征
- 批准号:
7043439 - 财政年份:2004
- 资助金额:
$ 21.17万 - 项目类别:
BIOCHEMISTRY AND GENETICS OF VITAMIN D RECEPTOR ACTIONS
维生素 D 受体作用的生物化学和遗传学
- 批准号:
6381315 - 财政年份:1998
- 资助金额:
$ 21.17万 - 项目类别:
BONE AND MINERAL METABOLISM IN BLACKS AND WHITES
黑人和白人的骨骼和矿物质代谢
- 批准号:
2079120 - 财政年份:1985
- 资助金额:
$ 21.17万 - 项目类别:
BONE AND MINERAL METABOLISM IN BLACKS AND WHITES
黑人和白人的骨骼和矿物质代谢
- 批准号:
3157467 - 财政年份:1985
- 资助金额:
$ 21.17万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 21.17万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 21.17万 - 项目类别:














{{item.name}}会员




